TA-8995

· Tanabe Pharma Corporation

Drug timelines are a Plus or Pro feature.

8 regulatory and trial events tracked for TA-8995, covering 2013-06-17 to 2016-10-03. Get the full timeline:

Most recent: Clinical Trial Update: ADME Study in Healthy Male Subjects With TA-8995 [Phase 1]